NASDAQ

Acumen Pharmaceuticals, Inc. (ABOS)

♥ 551 Thanks from members

Live price chart, market sentiment, and community perspectives for Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Daniel ShoreFounder: Acumen Pharmaceuticals TeamLeadership: Jon Kaiserman (Interim CEO)Leadership: Matt Zeller (CFO)Holder: Bain Capital Life SciencesHolder: Avoro Capital AdvisorsHolder: RA Capital ManagementSabirnetugAlzheimer's Therapeutics#ABOS#Acumen Pharmaceuticals#biotech#Alzheimer's treatment#sabirnetug